Long-term Follow-up of antithrombotIc Management Patterns in Acute Coronary Syndrome Patients in Asia-China Extension
Completed
- Conditions
- Acute Coronary Syndromes
- Registration Number
- NCT02305680
- Lead Sponsor
- AstraZeneca
- Brief Summary
This study is to describe the long-term antithrombotic management patterns in a real-life setting for patients hospitalized with an acute coronary syndrome in China.
- Detailed Description
This study is to describe the long-term (3 to 5 years after the acute coronary syndrome index event) antithrombotic management patterns in a real-life setting for patients hospitalized with an acute coronary syndrome (i.e. ST-segment Elevation Myocardial Infarction, Non-ST-segment Elevation Myocardial Infarction, Unstable Angina) in China.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2334
Inclusion Criteria
- Written informed consent has been provided.
- Contact Order Form has been provided
- Aged 18 years or older.
- Enrolled in EPICOR Asia study and completed the 2 year follow-up.
Exclusion Criteria
- Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient (e.g. tourist, non-native speaker or does not understand the local language, psychiatric disturbances, alcohol or drug abuse).
- Already included in the EPICOR Asia-China Extension observational study.
- Presence of serious/severe co-morbidities in the opinion of the investigator which may limit short term (i.e. 6 month) life expectancy.
- Current participation in an interventional clinical trial.
- Patients receiving ticagrelor beyond 12 months and other off label use.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Long-term antithrombotic management patterns in a real-life setting by assessing the medication and treatment prescribed by physicians From 2 years after the acute coronary syndrome index event, assessed up to 5 years
- Secondary Outcome Measures
Name Time Method Clinical outcomes by record the number and type of cardiovascular and non-cardiovascular events From 2 years after the acute coronary syndrome index event, assessed up to 5 years Quality of life by assessing EQ-5D questionnaire. 2 years,2.5years,3years,3.5years,4years,4.5years,5years after the acute coronary syndrome index event Health care resource consumption and related costs by assessing the detail hospitalization and outpatient cost. From 2 years after the acute coronary syndrome index event, assessed up to 5 years
Trial Locations
- Locations (1)
Research Site
🇨🇳Zhenjiang, China